Who's Buying or Selling Bright Minds Biosciences Inc (DRUG) Stock Today?

NAS:DRUG (USA) Ordinary Shares

$ 59.46 -1.16 (-1.91%) 04:00 PM EST

P/E:

At Loss

P/B:

2.65

Market Cap:

$ 588.22M

Enterprise V:

$ 366.78M

Volume:

91.52K

Avg Vol (2M):

166.80K

Warning! GuruFocus detected 1 Severe warning sign with DRUG. Try a 7-Day Free Trial to check it out.

Trade In:

Volume:

91.52K

Market Cap $:

588.22M

PE Ratio:

At Loss

Avg Vol (2M):

166.80K

Enterprise Value $:

366.78M

PB Ratio:

2.65

What is a stock summary page? Click here for an overview. Powered by GuruAPI

DRUG Number of Guru Trades

DRUG Volume of Guru Trades

Which ETFs traded it? ↓

DRUG Daily Net ETF Flow

Dollars ETFs put into or pulled out of DRUG each day, net of sells, against the share price.

DRUG Daily Net ETF Share Flow

Shares ETFs added or removed each day, net, as a share of DRUG's shares outstanding, against the share price.

Gurus Latest Trades with NAS:DRUG

No Available Data

NAS:DRUG is held by these investors

No Available Data

Top ETF Buyers

1W 2W 1M 3M

What each ETF bought and sold in this stock over the period, from the same daily data as the charts above. Sorted by net amount, so sorting ascending brings the heaviest sellers to the top.

ETF	ETF Name	Net Amount $Mil	Buy Amount $Mil	Sell Amount $Mil	Net Share Change	# of Days Traded	Current Shares

20/Page

Total 0

ETF Ownership

Every ETF holding the stock, largest position first. Change covers the gap between each fund's last two reports, so a fund that held still shows none.

ETF	ETF Name	Shares	% of Shares Out	Change (Last Report)	Action	Report Date	Price Range

20/Page

Total 0

Guru Commentaries on NAS:DRUG

No fund manager commentary yet.

Browse all fund letters →

News about NAS:DRUG

Total 0

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by FactSet. Analyst estimates data is sourced from both Refinitiv and FactSet, with priority given to Refinitiv data. Data is updated daily.